Vincerx Pharma Inc
NASDAQ:VINC

Watchlist Manager
Vincerx Pharma Inc Logo
Vincerx Pharma Inc
NASDAQ:VINC
Watchlist
Price: 0.0515 USD -4.63% Market Closed
Market Cap: 269.3k USD

Net Margin
Vincerx Pharma Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-30.1m
/
Revenue
0

Net Margin Across Competitors

Vincerx Pharma Inc
Glance View

Market Cap
269.3k USD
Industry
Biotechnology

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California and currently employs 56 full-time employees. The company went IPO on 2020-03-10. The Company’s small molecule drug program includes VIP152, which is a highly selective, clinical-stage positive transcription elongation factor-beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. The firm's antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924 (targeting CXCR5), which are ADC compounds addressing known and novel oncology targets. The Company’s bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors.

VINC Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-30.1m
/
Revenue
0
What is the Net Margin of Vincerx Pharma Inc?

Based on Vincerx Pharma Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top